• 1. Diabetic Foot Care Center, Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu Sichuan, 610041, P.R.China;
  • 2. Department of Endocrinology and Metabolism, Gansu Provincial Hospital, Lanzhou Gansu, 730000, P.R.China;
RAN Xingwu, Email: ranxingwu@163.com
Export PDF Favorites Scan Get Citation

Objective To review the research progress of adrenergic β-antagonists on wounds and diabetic chronic cutaneous ulcers healing in recent years, and to investigate its application prospect in diabetic foot ulcer (DFU).Methods The latest literature about the role of adrenergic β-antagonists in wounds and diabetic chronic cutaneous ulcers healing was extensively reviewed, and the mechanisms of adrenergic β-antagonists for wounds and its potential benefit for DFU were analyzed thoroughly.Results The adrenergic β-antagonists can accelerate the wound healing. The possible mechanisms include accelerating re-epithelialization, promoting angiogenesis, improving neuropathy, and regulating inflammation and growth factors, etc. At present clinical research data showed that the adrenergic β-antagonists may be an adjuvant treatment for diabetic chronic cutaneous ulcers.Conclusion Adrenergic β-antagonists maybe promote the healing of wounds and diabetic chronic cutaneous ulcers. However, more long-term follow-up and high-quality randomized control studies are needed to further verify their efficacy and safety for DFU.

Citation: SUN Shiyi, MA Jing, RAN Xingwu. Mechanisms of adrenergic β-antagonist for wounds and its application prospect in diabetic foot ulcers. Chinese Journal of Reparative and Reconstructive Surgery, 2020, 34(12): 1630-1634. doi: 10.7507/1002-1892.202002063 Copy

  • Previous Article

    Research progress in creep characteristics of lumbar intervertebral disc
  • Next Article

    梯形推进真皮脂肪瓣技术在乳腺癌整形保乳术中的应用